The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein

[1]  J. Minna,et al.  DNA methylation-associated inactivation of TGFβ-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancers , 2005, British journal of cancer.

[2]  G. Paul,et al.  14‐3‐3 Proteins: Regulators of numerous eukaryotic proteins , 2005, IUBMB life.

[3]  O. Opitz.  Telomeres, telomerase and malignant transformation. , 2005, Current molecular medicine.

[4]  Jane Y. Wu,et al.  Cutting Edge: Bone Morphogenetic Protein Antagonists Drm/Gremlin and Dan Interact with Slits and Act as Negative Regulators of Monocyte Chemotaxis12 , 2004, The Journal of Immunology.

[5]  Lin Kah Wai.  Telomeres, telomerase, and tumorigenesis--a review. , 2004, MedGenMed : Medscape general medicine.

[6]  R. Zeller,et al.  Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis , 2004, Development.

[7]  M. Khokha,et al.  Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning , 2003, Nature Genetics.

[8]  Takashi Tsuruo,et al.  Regulation of Kinase Activity of 3-Phosphoinositide-dependent Protein Kinase-1 by Binding to 14-3-3* , 2002, The Journal of Biological Chemistry.

[9]  D. Blair,et al.  Drm/Gremlin transcriptionally activates p21(Cip1) via a novel mechanism and inhibits neoplastic transformation. , 2002, Biochemical and biophysical research communications.

[10]  I. Newsham,et al.  The 4.1/ezrin/radixin/moesin domain of the DAL-1/Protein 4.1B tumour suppressor interacts with 14-3-3 proteins. , 2002, The Biochemical journal.

[11]  R. Harland,et al.  Mutation and Analysis of Dan, the Founding Member of the Dan Family of Transforming Growth Factor β Antagonists , 2001, Molecular and Cellular Biology.

[12]  A. Nakagawara,et al.  Overexpression of DAN causes a growth suppression in p53-deficient SAOS-2 cells. , 2000, Biochemical and biophysical research communications.

[13]  C. Hensey,et al.  Gremlins, glomeruli and diabetic nephropathy< , 2000, Current opinion in nephrology and hypertension.

[14]  W. Modi,et al.  DRM/GREMLIN (CKTSF1B1) maps to human chromosome 15 and is highly expressed in adult and fetal brain , 2000, Cytogenetic and Genome Research.

[15]  B. Bardot,et al.  Biosynthesis, Post-translation Modification, and Functional Characterization of Drm/Gremlin* , 2000, The Journal of Biological Chemistry.

[16]  S. Masters,et al.  14-3-3 proteins: structure, function, and regulation. , 2000, Annual review of pharmacology and toxicology.

[17]  J. Rodríguez-León,et al.  The BMP antagonist Gremlin regulates outgrowth, chondrogenesis and programmed cell death in the developing limb. , 1999, Development.

[18]  J. I. Izpisúa Belmonte,et al.  Control of vertebrate limb outgrowth by the proximal factor Meis2 and distal antagonism of BMPs by Gremlin. , 1999, Molecular cell.

[19]  Andrew P. McMahon,et al.  Signal relay by BMP antagonism controls the SHH/FGF4 feedback loop in vertebrate limb buds , 1999, Nature.

[20]  J. Rossant,et al.  A mouse cerberus/Dan-related gene family. , 1999, Developmental biology.

[21]  S. Tsuji,et al.  14-3-3 protein eta chain gene (YWHAH) polymorphism and its genetic association with schizophrenia. , 1999, American journal of medical genetics.

[22]  S. Kornbluth,et al.  Maintenance of G2 arrest in the Xenopus oocyte: a role for 14‐3‐3‐mediated inhibition of Cdc25 nuclear import , 1999, The EMBO journal.

[23]  R. McPherson,et al.  14-3-3 Facilitates Ras-Dependent Raf-1 Activation In Vitro and In Vivo , 1998, Molecular and Cellular Biology.

[24]  R. Harland,et al.  The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. , 1998, Molecular cell.

[25]  C. Widmann,et al.  14-3-3 Proteins Interact with Specific MEK Kinases* , 1998, The Journal of Biological Chemistry.

[26]  A. Kosaki,et al.  14-3-3β Protein Associates with Insulin Receptor Substrate 1 and Decreases Insulin-stimulated Phosphatidylinositol 3′-Kinase Activity in 3T3L1 Adipocytes* , 1998, The Journal of Biological Chemistry.

[27]  L. Topol,et al.  Identification of drm, a novel gene whose expression is suppressed in transformed cells and which can inhibit growth of normal but not transformed cells in culture , 1997, Molecular and cellular biology.

[28]  A. Craparo,et al.  14-3-3 (ε) Interacts with the Insulin-like Growth Factor I Receptor and Insulin Receptor Substrate I in a Phosphoserine-dependent Manner* , 1997, The Journal of Biological Chemistry.

[29]  H. Wakui,et al.  Interaction of the Ligand-activated Glucocorticoid Receptor with the 14-3-3η Protein* , 1997, The Journal of Biological Chemistry.

[30]  R. Honda,et al.  14-3-3 zeta protein binds to the carboxyl half of mouse wee1 kinase. , 1997, Biochemical and biophysical research communications.

[31]  Elizabeth Yang,et al.  Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL , 1996, Cell.

[32]  A. Aitken.  14-3-3 and its possible role in co-ordinating multiple signalling pathways. , 1996, Trends in cell biology.

[33]  V. Dixit,et al.  14-3-3 Proteins Associate with A20 in an Isoform-specific Manner and Function Both as Chaperone and Adapter Molecules* , 1996, The Journal of Biological Chemistry.

[34]  S. J. Kim,et al.  CUMC-6, a new diploid human cell line derived from a squamous carcinoma of the uterine cervix. , 1996, Gynecologic oncology.

[35]  H. Leffers,et al.  Assignment of the human genes encoding 14,3-3 Eta (YWHAH) to 22q12, 14-3-3 zeta (YWHAZ) to 2p25.1-p25.2, and 14-3-3 beta (YWHAB) to 20q13.1 by in situ hybridization. , 1996, Genomics.

[36]  I. Petersen,et al.  Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer. , 1996, Oncogene.

[37]  T. Isobe,et al.  Identification of the Site of Interaction of the 14-3-3 Protein with Phosphorylated Tryptophan Hydroxylase (*) , 1995, The Journal of Biological Chemistry.

[38]  F. McCormick,et al.  Bcr and Raf form a complex in vivo via 14‐3‐3 proteins. , 1995, The EMBO journal.

[39]  N. Isaacs.  Cystine knots. , 1995, Current opinion in structural biology.

[40]  C. Bird,et al.  p53 mutations in cervical carcinogenesis--low frequency and lack of correlation with human papillomavirus status. , 1994, British Journal of Cancer.

[41]  A. Pardee,et al.  Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. , 1992, Science.

[42]  W. Mason,et al.  Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours , 1992, The Lancet.

[43]  N. Shimizu,et al.  cDNA cloning and chromosome assignment of the gene for human brain 14–3–3 protein η chain , 1992, Journal of neuroscience research.

[44]  N. Shimizu,et al.  cDNA cloning and chromosome assignment of the gene for human brain 14-3-3 protein eta chain. , 1992, Journal of Neuroscience Research.

[45]  C. Harris,et al.  Oncogenes and tumor-suppressor genes. , 1991, Environmental health perspectives.

[46]  J. Bishop.  Molecular themes in oncogenesis , 1991, Cell.

[47]  K. Araki,et al.  Molecular cloning of cDNA coding for brain-specific 14-3-3 protein, a protein kinase-dependent activator of tyrosine and tryptophan hydroxylases. , 1988, Proceedings of the National Academy of Sciences of the United States of America.